Correlation Engine 2.0
Clear Search sequence regions

  • biosensors (9)
  • cathepsin (6)
  • elisa (1)
  • female (1)
  • gold (1)
  • humans (1)
  • ovarian cancer (4)
  • patients (2)
  • plasma (4)
  • plasma (1)
  • rats (1)
  • receptor (1)
  • SPRi (2)
  • volunteers (1)
  • Sizes of these terms reflect their relevance to your search.

    Cathepsin S is an emerging marker for ovarian cancer. Two 'analytically specific' SPRi biosensors for the determination of Cath S have been developed. The reception part of one of the biosensors consists of the rat monoclonal antibody specific for cathepsin S attached to the gold surface via covalent bonds with cysteamine linker, while the second biosensor consists of the inhibitor LY3000328 attached via hydrophobic interaction with the 1-octadecanothiol linker. Under optimized conditions, in terms of pH and receptor concentration, both biosensors have linear response ranges between LOQ (0.14 ng mL-1) and 2.5 ng mL-1, which is suitable for the determination of Cath S in blood plasma samples of ovarian cancer patients and healthy individuals, after corresponding dilution with 0.15 M PBS buffer. Precision and recoveries are quite acceptable: below 7% and 98-101% respectively for the biosensor with antibody, and below 12% and 101-103% for the biosensor with inhibitor. The biosensors were validated by the determination of Cath S in series of plasma from ovarian cancer patients and healthy volunteers using both biosensors and ELISA, giving Pearson coefficients close to 1. Plasma Cath S concentration can be used as an ovarian cancer marker, in view of the highly elevated concentrations detected. Copyright © 2020 Elsevier B.V. All rights reserved.


    Lukasz Oldak, Anna Sankiewicz, Beata Żelazowska-Rutkowska, Bogdan Cylwik, Zenon Lukaszewski, Marcin Skoczylas, Ewa Gorodkiewicz. Two SPRi biosensors for the determination of cathepsin S in blood plasma. Talanta. 2021 Apr 01;225:121900

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33592693

    View Full Text